Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1959 1
1961 1
1963 4
1964 1
1966 1
1968 1
1971 3
1972 1
1973 4
1974 3
1975 3
1976 6
1977 6
1978 4
1979 5
1980 1
1982 7
1983 6
1984 7
1985 6
1986 1
1987 5
1988 6
1989 3
1990 2
1991 3
1992 3
1993 4
1994 14
1995 11
1996 13
1997 19
1998 16
1999 29
2000 32
2001 38
2002 32
2003 30
2004 26
2005 37
2006 32
2007 43
2008 39
2009 30
2010 30
2011 34
2012 43
2013 42
2014 51
2015 53
2016 56
2017 77
2018 84
2019 86
2020 103
2021 92
2022 118
2023 85
2024 88
2025 110
2026 57

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,531 results

Results by year

Filters applied: . Clear all
Page 1
[Preface].
Nishida M, Kanda Y. Nishida M, et al. Among authors: kanda y. Nihon Yakurigaku Zasshi. 2022;157(2):110. doi: 10.1254/fpj.21109. Nihon Yakurigaku Zasshi. 2022. PMID: 35228440 Japanese. No abstract available.
Targeting PDGF signaling of cancer-associated fibroblasts blocks feedback activation of HIF-1α and tumor progression of clear cell ovarian cancer.
Mori Y, Okimoto Y, Sakai H, Kanda Y, Ohata H, Shiokawa D, Suzuki M, Yoshida H, Ueda H, Sekizuka T, Tamura R, Yamawaki K, Ishiguro T, Mateos RN, Shiraishi Y, Yatabe Y, Hamada A, Yoshihara K, Enomoto T, Okamoto K. Mori Y, et al. Among authors: kanda y. Cell Rep Med. 2024 May 21;5(5):101532. doi: 10.1016/j.xcrm.2024.101532. Epub 2024 Apr 25. Cell Rep Med. 2024. PMID: 38670097 Free PMC article.
Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia.
Wakita S, Sakaguchi M, Oh I, Kako S, Toya T, Najima Y, Doki N, Kanda J, Kuroda J, Mori S, Satake A, Usuki K, Ueki T, Uoshima N, Kobayashi Y, Kawata E, Tajika K, Nagao Y, Shono K, Shibusawa M, Tadokoro J, Kayamori K, Hagihara M, Uchiyama H, Uchida N, Kubota Y, Kimura S, Nagoshi H, Ichinohe T, Kurosawa S, Motomura S, Hashimoto A, Muto H, Sato E, Ogata M, Mitsuhashi K, Ando J, Marumo A, Omori I, Fujiwara Y, Terada K, Yui S, Arai K, Kitano T, Miyata M, Kurosawa A, Mizoguchi A, Komatsu N, Fukuda T, Ohashi K, Kanda Y, Inokuchi K, Yamaguchi H. Wakita S, et al. Among authors: kanda y. Blood Adv. 2022 Jan 11;6(1):238-247. doi: 10.1182/bloodadvances.2021004292. Blood Adv. 2022. PMID: 34448807 Free PMC article.
[Preface].
Kanda Y, Kurokawa J. Kanda Y, et al. Nihon Yakurigaku Zasshi. 2021;156(4):207. doi: 10.1254/fpj.21038. Nihon Yakurigaku Zasshi. 2021. PMID: 34193696 Japanese. No abstract available.
Heterogeneity of Survival Benefit Conferred By Letermovir.
Akahoshi Y, Nakasone H, Takenaka K, Ara T, Tada Y, Doki N, Uchida N, Tanaka M, Hasegawa Y, Takeda W, Nishida T, Ishikawa J, Kurita N, Sawa M, Onizuka M, Kako S, Fujiwara SI, Kataoka K, Kawamura K, Fukuda T, Atsuta Y, Yakushijin K, Kanda Y. Akahoshi Y, et al. Among authors: kanda y. Transplant Cell Ther. 2025 Jul;31(7):461.e1-461.e12. doi: 10.1016/j.jtct.2025.04.010. Epub 2025 Apr 28. Transplant Cell Ther. 2025. PMID: 40306552
Efficacy of Total-Body Irradiation-based Intensified Myeloablative Regimens for Acute Leukemia-An International Collaborative Study.
Arai Y, Brazauskas R, He N, Al-Homsi AS, Chhabra S, Battiwalla M, Yanada M, Steinberg A, Diaz Perez MA, Hong S, Kanda J, Bashey A, Frangoul HA, Badawy SM, Verdonck LF, Lazarus HM, Yared JA, Hashem H, Sharma A, Aljurf M, Dias AL, Abid MB, Wirk B, Freytes CO, Zeidan AM, Gergis U, Beitinjaneh A, Askar M, Pu JJ, Lehmann LE, Rangarajan HG, Wood WA, Hashmi S, Yano S, Kako S, Ozawa Y, Doki N, Kanda Y, Fukuda T, Katayama Y, Ichinohe T, Tanaka J, Teshima T, Okamoto S, Atsuta Y, Saber W. Arai Y, et al. Among authors: kanda y. EJHaem. 2025 May 28;6(3):e70061. doi: 10.1002/jha2.70061. eCollection 2025 Jun. EJHaem. 2025. PMID: 40438703 Free PMC article.
The hepatic niche leads to aggressive natural killer cell leukemia proliferation through the transferrin-transferrin receptor 1 axis.
Kameda K, Yanagiya R, Miyatake Y, Carreras J, Higuchi H, Murayama H, Ishida T, Ito A, Iida S, Fukuhara N, Harigae H, Fujioka Y, Takahashi N, Wada H, Ishida F, Nakazawa H, Ishihara R, Murakami Y, Tagawa H, Matsuura T, Nakagawa S, Iwabuchi S, Hashimoto S, Imadome KI, Nakamura N, Ishizawa K, Kanda Y, Ando K, Kotani A. Kameda K, et al. Among authors: kanda y. Blood. 2023 Jul 27;142(4):352-364. doi: 10.1182/blood.2022018597. Blood. 2023. PMID: 37146246 Free article.
Classical and Late-Onset SOS/VOD After Allogeneic HSCT: A Japanese Transplant Registry Analysis.
Masuda K, Kataoka K, Sakurai M, Najima Y, Harada N, Ukita S, Uchida N, Doki N, Fukuda T, Tanaka M, Ohigashi H, Ishikawa J, Yoshihara S, Sawa M, Ota S, Kanda Y, Nishida T, Onizuka M, Atsuta Y, Nakasone H, Yakushijin K. Masuda K, et al. Among authors: kanda y. Am J Hematol. 2025 Aug;100(8):1283-1294. doi: 10.1002/ajh.27715. Epub 2025 May 19. Am J Hematol. 2025. PMID: 40387331 Free PMC article.
1,531 results